Dr. Thébaud awarded Canada Research Chair
The federal government announced a new round of Canada Research Chairs in November 2024, including three based at The Ottawa Hospital. Dr. Bernard Thébaud, neonatologist and senior scientist in OHRI’s Regenerative Medicine Program, was appointed Tier 1 Canada...
Grant to support Canada-wide trial of cell therapy for preterm infants
Dr. Bernard Thébaud was awarded $2.8 million from the Canadian Institutes of Health Research Clinical Trials Fund for a Phase 2 clinical trial using mesenchymal stromal cells (MSCs) to treat bronchopulmonary dysplasia (BPD) in premature babies. Very premature babies...
Mahnaz Nazari awarded PHA Canada Scholarship
Congratulations to Mahnaz on the receipt of the 2024 Bell Family Pediatric PH Research Scholarship awarded by PHA Canada! You can read more about her award here: https://phacanada.ca/Research/Research-Scholarships
First patient treated in world-first cell therapy trial to heal the lungs of preterm babies
Dr. Thébaud’s team has treated the first patient in an innovative cell therapy clinical trial - the first of its kind in the world - that aims to prevent very premature babies from developing a chronic lung disease called bronchopulmonary dysplasia (BPD). Premature...
